Lieder Helmut R, Baars Theodor, Kahlert Philipp, Kleinbongard Petra
Institut für Pathophysiologie, Universitätsklinikum Essen Westdeutsches Herz- und Gefäßzentrum, Essen, Germany.
Klinik für Kardiologie, Universitätsklinikum Essen Westdeutsches Herz- und Gefäßzentrum, Essen, Germany.
Physiol Rep. 2016 Aug;4(15). doi: 10.14814/phy2.12874.
Stent implantation into aortocoronary saphenous vein grafts (SVG) releases particulate debris and soluble vasoactive mediators, for example, serotonin. We now analyzed effects of the soluble mediators released into the coronary arterial blood during stent implantation on vasomotion of isolated rat epicardial coronary artery segments and on coronary flow and left ventricular developed pressure in isolated perfused rat hearts. Coronary blood was retrieved during percutaneous SVG intervention using a distal occlusion/aspiration protection device in nine symptomatic patients with stable angina pectoris and a flow-limiting SVG stenosis. The blood was separated into particulate debris and plasma. Responses to coronary plasma were determined in isolated rat epicardial coronary arteries and in isolated, constant pressure-perfused rat hearts (±nitric oxide synthase [NOS] inhibition and ±serotonin receptor blockade, respectively). Coronary aspirate plasma taken after stent implantation induced a stronger vasoconstriction of rat epicardial coronary arteries (52 ± 8% of maximal potassium chloride induced vasoconstriction [% KClmax = 100%]) than plasma taken before stent implantation (12 ± 8% of KClmax); NOS inhibition augmented this vasoconstrictor response (to 110 ± 15% and 24 ± 9% of KClmax). Coronary aspirate plasma taken after stent implantation reduced in isolated perfused rat hearts only under NOS inhibition coronary flow by 17 ± 3% and left ventricular developed pressure by 25 ± 4%. Blockade of serotonin receptors abrogated these effects. Coronary aspirate plasma taken after stent implantation induces vasoconstriction in isolated rat epicardial coronary arteries and reduces coronary flow and left ventricular developed pressure in isolated perfused rat hearts with pharmacologically induced endothelial dysfunction.
将支架植入主动脉冠状动脉大隐静脉移植物(SVG)会释放颗粒碎片和可溶性血管活性介质,例如血清素。我们现在分析了支架植入过程中释放到冠状动脉血液中的可溶性介质对离体大鼠心外膜冠状动脉段血管运动以及对离体灌注大鼠心脏的冠状动脉血流和左心室舒张末压的影响。在9例有症状的稳定型心绞痛且存在限流性SVG狭窄的患者经皮SVG介入治疗期间,使用远端闭塞/抽吸保护装置采集冠状动脉血液。将血液分离为颗粒碎片和血浆。分别在离体大鼠心外膜冠状动脉和离体恒压灌注大鼠心脏中(分别±一氧化氮合酶[NOS]抑制和±血清素受体阻断)测定对冠状动脉血浆的反应。支架植入后采集的冠状动脉抽吸血浆比支架植入前采集的血浆能引起大鼠心外膜冠状动脉更强的血管收缩(最大氯化钾诱导的血管收缩的52±8%[最大氯化钾收缩率=100%]);NOS抑制增强了这种血管收缩反应(分别达到最大氯化钾收缩率的110±15%和24±9%)。仅在NOS抑制下,支架植入后采集的冠状动脉抽吸血浆使离体灌注大鼠心脏的冠状动脉血流减少17±3%,左心室舒张末压降低25±4%。血清素受体阻断消除了这些作用。支架植入后采集的冠状动脉抽吸血浆在药理学诱导内皮功能障碍的离体大鼠心外膜冠状动脉中诱导血管收缩,并降低离体灌注大鼠心脏的冠状动脉血流和左心室舒张末压。